CUX2 rs3763764: Genetic Variation and Macular Microarchitecture
The rs3763764 variant is a common single-nucleotide polymorphism located in the region of the cut-like homeobox 2 (CUX2) gene on chromosome 12. Genome-wide association and fine-mapping investigations have identified this regulatory variant as being linked to ocular microarchitecture and subtle variation in macular structure. While the statistical evidence linking rs3763764 to retinal vulnerability is moderate, it does not cause monogenic vision loss on its own.
What each genotype means
Typical macular microarchitecture
You carry two copies of the C allele at this regulatory locus near the CUX2 gene. In genome-wide association studies, this baseline genotype is associated with standard ocular structural dimensions and macular microarchitecture. It does not carry the subtle shifts in retinal structural vulnerability linked to the alternative allele.
Carried by approximately 35% to 40% of individuals in European and East Asian populations, and more common in African ancestries.
Intermediate macular thickness variation
You carry one copy of the T allele and one copy of the C allele. Genome-wide analyses have identified this regulatory variant as influencing ocular structural parameters and sub-macular retinal layer thickness. Carrying a single T allele is associated with moderate, statistical variation in retinal microarchitecture, though it does not represent an independent clinical diagnosis.
Carried by roughly 45% to 50% of individuals across European and East Asian populations.
Altered ocular structural vulnerability
You carry two copies of the T allele associated with regulatory modulation near CUX2. Statistical genetic studies link this genotype to measurable alterations in macular microarchitecture and subtle variation in ocular structural integrity. These findings reflect small population-level biometric variations rather than deterministic ocular disease.
Carried by approximately 15% to 20% of people of European and East Asian ancestry, but is relatively uncommon in individuals of African ancestry.
Genomic Location and the Nature of rs3763764
The single-nucleotide polymorphism rs3763764 resides within the chromosomal band 12q24.11 in the non-coding regulatory expanse linked to the CUX2 locus. Because this variant does not alter the primary amino acid sequence of a protein, genomic mapping indicates that it functions primarily as an expression quantitative trait locus or an epigenetic modifier, potentially modulating transcriptional efficiency or chromatin accessibility in nearby genomic territory. In human genetics, common regulatory variants like rs3763764 frequently alter transcription factor binding motifs, leading to subtle downstream shifts in gene expression across specific tissues rather than outright loss-of-function.
Biological Role of the CUX2 Transcription Factor
The CUX2 gene encodes Cut Like Homeobox 2, a homeodomain-containing transcription factor that plays essential roles in neurogenesis, cellular differentiation, and dendritic branching. In mammalian neural development, CUX2 is heavily expressed in upper-layer cortical neurons and is critical for regulating synaptic plasticity, dendritic spine architecture, and axonal arborization. Because the retina is an embryonic extension of the central nervous system, homeobox transcription factors such as CUX2 are also involved in retinal cell patterning and maintaining the microstructural integrity of neural layers within the eye, including the intricate circuitry supporting the macular region.
Evidence for Association with Ocular Microarchitecture
Large-scale genome-wide association studies (GWAS) and fine-mapping initiatives have evaluated rs3763764 for its connection to quantitative ocular parameters, including retinal layer thickness, vascular density, and susceptibility to macular degeneration. Current literature categorizes the statistical evidence for rs3763764 as moderate. The variant demonstrates an association with subtle variations in macular microarchitecture and structural vulnerability rather than acting as a deterministic driver of severe retinal dystrophy. As with many complex ocular phenotypes, its observable effect size is modest, meaning that it operates alongside numerous other polygenic factors and environmental influences.
Allele Frequencies Across Ancestral Populations
Data from large population databases, including gnomAD and the 1000 Genomes Project, indicate that rs3763764 is a frequent polymorphism worldwide. In European (EUR) and East Asian (EAS) ancestral groups, the minor allele frequency is approximately 0.40, indicating that a substantial portion of individuals carry at least one copy of the alternate allele. Frequencies may fluctuate somewhat across other global ancestries, such as African and South Asian cohorts, reflecting evolutionary drift in non-coding regulatory architecture. Because of its common prevalence, possessing this variant reflects normal human genetic diversity rather than a rare hereditary mutation.
Clinical Perspective and Lifestyle Context
Finding that you carry an alternate allele at rs3763764 is not a diagnosis of an eye condition, nor does it guarantee that you will experience visual impairment. Genetic predispositions to ocular structural variation are mediated heavily by age, smoking status, cardiovascular health, and dietary intake of protective antioxidants like lutein and zeaxanthin. Individuals interested in supporting their long-term ocular health can focus on standard preventive measures, such as scheduling comprehensive dilated eye examinations, maintaining healthy blood pressure, protecting eyes from ultraviolet light, and discussing any vision changes directly with an optometrist or ophthalmologist.
How common is this variant?
The minor allele frequency for rs3763764 is approximately 0.40 across both European (EUR) and East Asian (EAS) populations, with similar high-frequency distributions observed across broader global reference cohorts.
Frequently asked questions
Does carrying the rs3763764 variant mean I will develop macular degeneration?
No. The rs3763764 variant is associated with subtle differences in retinal microarchitecture and general structural vulnerability, but it does not cause disease by itself. Common variants of this kind confer small statistical shifts in trait variance, and the vast majority of carriers maintain normal, healthy vision.
What is the CUX2 gene responsible for in the human body?
CUX2 encodes a homeobox transcription factor primarily known for orchestrating neuronal differentiation, dendrite branching, and synapse formation. Because the retina is part of the central nervous system, CUX2 is thought to participate in the structural development and organization of ocular neural cells.
Can I test for rs3763764 through consumer DNA testing?
Many commercial microarray and whole-genome sequencing platforms include rs3763764 on their genotyping chips or in raw sequence output. However, clinical eye evaluations do not typically test for this variant, as standard medical genetics panels prioritize high-penetrance monogenic markers rather than modest polygenic associations.
What steps can I take to protect my retinal and macular health?
Regardless of your genotype, the best protective measures for the macula include avoiding tobacco smoke, eating a diet rich in leafy green vegetables and omega-3 fatty acids, wearing UV-blocking sunglasses outdoors, and getting regular comprehensive dilated eye exams from an eye care specialist.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3763764?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29